Chronic myeloid leukemia
What is chronic myeloid leukemia?
Chronic myeloid leukemia (CML) is a cancer in which the bone marrow makes too many granulocytes (a type of white blood cells). It develops slowly and is usually diagnosed in the chronic phase when it can be effectively treated.
Risks for chronic leukemia
Chronic leukemia includes chronic lymphocytic leukemia (CLL) and chronic myeloid leukemia (CML). Risks for chronic leukemia include family history and high doses of radiation.
Symptoms of leukemia
Symptoms may vary depending on whether you have an acute or chronic type of leukemia.
Diagnosis of leukemia
Tests to diagnose leukemia, such as blood tests, are done when symptoms or routine tests suggest a problem. Learn about diagnosing leukemia.
Staging chronic myeloid leukemia
Chronic myeloid leukemia (CML) is given a phase based on the number of blast cells in the blood and bone marrow. The 3 phases of CML are chronic, accelerated and blast.
Disease progression of chronic myeloid leukemia
Chronic myeloid leukemia (CML) usually progresses slowly. With treatment, it can stay in the chronic phase for many years before moving into the accelerated or blast phase.
Prognosis and survival for chronic myeloid leukemia
Prognosis estimates the outcome for chronic myeloid leukemia (CML). It depends on many factors including age, the phase of CML, the Philadelphia (Ph) chromosome and blood cell counts.
Treatments for chronic myeloid leukemia
Chronic myeloid leukemia (CML) is treated with targeted therapy. Other treatments may be used if CML doesn't respond to, or stops responding to, targeted therapy. Treatment plans are based on if CML is in the chronic, accelerated or blast phase.
Supportive care for leukemia
Supportive care helps people with physical, practical, emotional and spiritual challenges of leukemia.
Chronic myeloid leukemia statistics
Cancer statistics tell us how many people in Canada are diagnosed with and die from chronic myeloid leukemia (CML) in a certain time frame.